InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

MESOBLAST LTD

MESO Clue Score68
Australia Fiscal year ends June CIK 0001345099
$14.29 +3.93% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $14.29 +157.94% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2017Revenue2.4Net income−76.8EPS, diluted−0.19Fiscal year 2018Revenue17.3 +618.9%Net income−35.3EPS, diluted−0.08Fiscal year 2019Revenue16.7 −3.6%Net income−89.8EPS, diluted−0.18Fiscal year 2020Revenue32.2 +92.3%Net income−77.9EPS, diluted−0.15Fiscal year 2021Revenue7.4 −76.9%Net income−98.8EPS, diluted−0.16Fiscal year 2022Revenue10.2 +37.4%Net income−91.3EPS, diluted−0.13Fiscal year 2023Revenue7.5 −26.5%Net income−81.9EPS, diluted−0.11Fiscal year 2024Revenue5.9 −21.3%Net income−88.0EPS, diluted−0.09Fiscal year 2025Revenue17.2 +191.4%Net income−102.1EPS, diluted−0.08
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.4 17.3 16.7 32.2 7.4 10.2 7.5 5.9 17.2
Growth +618.9% −3.6% +92.3% −76.9% +37.4% −26.5% −21.3% +191.4%
Net income −76.8 −35.3 −89.8 −77.9 −98.8 −91.3 −81.9 −88.0 −102.1
Growth
EPS, diluted −0.19 −0.08 −0.18 −0.15 −0.16 −0.13 −0.11 −0.09 −0.08
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2017Net margin−3,184.7%Fiscal year 2018Net margin−203.5%Fiscal year 2019Net margin−537.0%Fiscal year 2020Net margin−242.4%Fiscal year 2021Net margin−1,329.2%Fiscal year 2022Net margin−894.6%Fiscal year 2023Net margin−1,091.7%Free cash flow margin−847.0%Fiscal year 2024Net margin−1,490.3%Free cash flow margin−825.6%Fiscal year 2025Net margin−593.9%Free cash flow margin−294.4%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin −3,184.7% −203.5% −537.0% −242.4% −1,329.2% −894.6% −1,091.7% −1,490.3% −593.9%
Free cash flow margin n/a n/a n/a n/a n/a n/a −847.0% −825.6% −294.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−95.5Fiscal year 2018Operating cash flow−75.0Fiscal year 2019Operating cash flow−57.8Fiscal year 2020Operating cash flow−50.4Fiscal year 2021Operating cash flow−100.7Fiscal year 2022Operating cash flow−65.8Fiscal year 2023Operating cash flow−63.3Capital expenditure−0.3Free cash flow−63.5Fiscal year 2024Operating cash flow−48.5Capital expenditure−0.3Free cash flow−48.7Fiscal year 2025Operating cash flow−50.0Capital expenditure−0.7Free cash flow−50.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −95.5 −75.0 −57.8 −50.4 −100.7 −65.8 −63.3 −48.5 −50.0
Capital expenditure n/a n/a n/a n/a n/a n/a −0.3 −0.3 −0.7
Free cash flow n/a n/a n/a n/a n/a n/a −63.5 −48.7 −50.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash45.8Shareholders’ equity516.8Fiscal year 2018Cash37.8Total debt59.4Net cash (debt)−21.6Shareholders’ equity546.0Debt to equity0.11Fiscal year 2019Cash50.4Total debt81.3Net cash (debt)−30.9Shareholders’ equity481.1Debt to equity0.17Fiscal year 2020Cash129.3Total debt89.5Net cash (debt)39.9Shareholders’ equity549.3Debt to equity0.16Fiscal year 2021Cash136.9Total debt94.2Net cash (debt)42.6Shareholders’ equity581.4Debt to equity0.16Fiscal year 2022Cash60.4Total debt96.6Net cash (debt)−36.2Shareholders’ equity497.0Debt to equity0.19Fiscal year 2023Cash71.3Total debt108.8Net cash (debt)−37.4Shareholders’ equity501.8Debt to equity0.22Fiscal year 2024Cash63.0Total debt114.3Net cash (debt)−51.4Shareholders’ equity480.4Debt to equity0.24Fiscal year 2025Cash161.6Total debt121.9Net cash (debt)39.7Shareholders’ equity597.4Debt to equity0.20
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 45.8 37.8 50.4 129.3 136.9 60.4 71.3 63.0 161.6
Total debt n/a 59.4 81.3 89.5 94.2 96.6 108.8 114.3 121.9
Net cash (debt) n/a −21.6 −30.9 39.9 42.6 −36.2 −37.4 −51.4 39.7
Shareholders’ equity 516.8 546.0 481.1 549.3 581.4 497.0 501.8 480.4 597.4
Debt to equity n/a 0.11 0.17 0.16 0.16 0.19 0.22 0.24 0.20

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025
Margins
−3,740.3% −380.5% −590.6% −271.7% −1,340.2% −896.9% −1,094.5% −1,493.5% −592.0%
−3,184.7% −203.5% −537.0% −242.4% −1,329.2% −894.6% −1,091.7% −1,490.3% −593.9%
n/a n/a n/a n/a n/a n/a −847.0% −825.6% −294.4%
Spending
2,442.5% 380.2% 357.7% 174.7% 713.1% 321.4% 704.1% 672.9% 202.4%
n/a n/a n/a n/a n/a n/a 366.4% 423.2% 228.6%
n/a n/a n/a n/a n/a n/a 3.5% 4.6% 4.0%
Returns
−14.9% −6.5% −18.7% −14.2% −17.0% −18.4% −16.3% −18.3% −17.1%
−11.7% −5.1% −13.8% −10.6% −13.3% −13.8% −12.2% −13.1% −13.0%
Balance and payout
n/a 0.11 0.17 0.16 0.16 0.19 0.22 0.24 0.20
21.2% 21.1% 26.2% 25.1% 21.9% 24.9% 25.0% 28.2% 23.9%